trademan1

CNAT gapped up on clinical test results

Long
NASDAQ:CNAT   None
0
Gapped up recently on good results from of clinical trial of Emricasan
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.